REG - Fortis Frontier PLC - Transaction in Own Shares and Total Voting Rights

Fortis FrontierAnnouncement

Today 13:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260511:nRSK8377Da&default-theme=true

RNS Number : 8377D  Fortis Frontier PLC  11 May 2026

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Transaction in Own Shares and Total Voting Rights

 

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly
MyHealthChecked PLC), announces that on 8 May 2026, pursuant to the authority
approved by shareholders at the Company's Annual General Meeting of 28 April
2026, the Company purchased 96,790 ordinary shares of 1.5 pence each
("Ordinary Shares") at a price of 7.9p per share, representing approximately
0.30% of the Company's issued share capital.

 

Total Voting Rights

The Company intends that the purchased Ordinary Shares will be cancelled as
soon as practical. Following cancellation of the purchased Ordinary Shares,
the Company's total number of ordinary shares in issue shall be 32,451,976
Ordinary Shares.

 

The above figure of 32,451,976 Ordinary Shares should be used by shareholders
as the denominator for the calculations by which they will determine if they
are required to notify their interest in, or a change to their interest in,
the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information contact:

 

 Fortis Frontier PLC                                              www.fortisfrontierplc-ir.com (http://www.fortisfrontierplc-ir.com)
 Adam Reynolds, Executive Chairman                                via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)                          Tel: +44 (0)20 3368 3550
 Neil Baldwin / Dillon Wall

 Singer Capital Markets (Broker)                                  Tel: +44 (0)20 7496 3000
 James Serjeant / Russell Cook / Amber Higgs

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
                                   (mailto:fortisfrontier@walbrookpr.com)
 Paul McManus / Alice Woodings                                    Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading
subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell,
as defined in the AIM Rules for Companies. On the same day the Company changed
its name to Fortis Frontier PLC. The Board is now carefully considering the
strategic options available to it in order to maximise shareholder value.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSGPUQUAUPQGPG



            Copyright 2019 Regulatory News Service, all rights reserved